首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   432335篇
  免费   30055篇
  国内免费   6532篇
耳鼻咽喉   5681篇
儿科学   8934篇
妇产科学   11052篇
基础医学   60019篇
口腔科学   12671篇
临床医学   37037篇
内科学   86058篇
皮肤病学   9167篇
神经病学   30406篇
特种医学   16041篇
外国民族医学   134篇
外科学   66052篇
综合类   17702篇
现状与发展   20篇
一般理论   67篇
预防医学   21045篇
眼科学   10983篇
药学   36898篇
  62篇
中国医学   5111篇
肿瘤学   33782篇
  2021年   4870篇
  2020年   3811篇
  2019年   4753篇
  2018年   6642篇
  2017年   5235篇
  2016年   5296篇
  2015年   6616篇
  2014年   8911篇
  2013年   10060篇
  2012年   14285篇
  2011年   14931篇
  2010年   9042篇
  2009年   7995篇
  2008年   12411篇
  2007年   13259篇
  2006年   13227篇
  2005年   12268篇
  2004年   10808篇
  2003年   10476篇
  2002年   9864篇
  2001年   29272篇
  2000年   29897篇
  1999年   24880篇
  1998年   5878篇
  1997年   4910篇
  1996年   4324篇
  1995年   4071篇
  1994年   3594篇
  1993年   3152篇
  1992年   16404篇
  1991年   15118篇
  1990年   14428篇
  1989年   14178篇
  1988年   12813篇
  1987年   12233篇
  1986年   11282篇
  1985年   10466篇
  1984年   7012篇
  1983年   5675篇
  1982年   2764篇
  1979年   5564篇
  1978年   3381篇
  1977年   2988篇
  1975年   2676篇
  1974年   3114篇
  1973年   2893篇
  1972年   2851篇
  1971年   2796篇
  1970年   2523篇
  1969年   2561篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Whether the underlying mutations are homozygous, heterozygous, or co-inherited with other hemoglobinopathies, sickle cell disease is known to afflict the kidneys, leading to the clinical entity known as sickle cell nephropathy (SCN). Although common, SCN remains diagnostically elusive. Conventional studies performed in the context of renal disorders often fail to detect early stage SCN. This makes the quest for early diagnosis and treatment more challenging, and it increases the burden of chronic kidney disease-related morbidity among patients. Novel diagnostic tools have been employed to overcome this limitation. In this study, we discuss various biomarkers of SCN, including those employed in clinical practice and others recently identified in experimental settings, such as markers of vascular injury, endothelial dysfunction, tubulo-glomerular damage, and oxidative stress. These include kidney injury molecule-1, monocyte chemoattractant protein-1, N-acetyl-B-D-glucosaminidase, ceruloplasmin, orosomucoid, nephrin, and cation channels, among others. Furthermore, we explore the potential of novel biomarkers for refining diagnostic and therapeutic approaches and describe some obstacles that still need to be overcome. We highlight the importance of a collaborative approach to standardize the use of promising new biomarkers. Finally, we outline the limitations of conventional markers of renal damage as extensions of the pathogenic process occurring at the level of the organ and its functional subunits, with a discussion of the expected pattern of clinical and biochemical progression among patients with SCN.  相似文献   
2.
Major depressive disorder is a serious and common neuropsychiatric disorder that affects more than 350 million people worldwide. Electroconvulsive therapy is the oldest and most effective treatment available for the treatment of severe major depressive disorder. Electroconvulsive therapy modifies structural network changes in patients with major depressive disorder and schizophrenia. And it can also affect neuroinflammatory responses and may have neuroprotective effects. Electroconvulsive therapy plays an irreplaceable role in the treatment of major depressive disorder.  相似文献   
3.
目的分析超声引导下经皮肺穿刺活检术术后并发症的相关影响因素。 方法收集2015年1月至2017年12月于西部战区总医院住院并在超声引导下行经皮肺穿刺活检术的205例患者临床资料,分析205例患者穿刺术后病理结果及并发症发生率,探讨超声引导下经皮肺穿刺活检术术后并发症的相关影响因素。 结果205例患者行超声引导下经皮肺穿刺活检术,术后并发出血8例,占3.9%(8/205),术后发热3例,占1.46% (3/205),为低热,且予以对症治疗后均恢复正常,无严重并发症发生。术后出血的发生率在不同性别、年龄、BMI及病灶类型的患者中无显著差异(P>0.05),且吸烟对患者术后出血率也无显著影响(P>0.05);但有基础疾病的患者其术后出血率更高(P=0.005),且病灶直径越小,术后越容易并发出血(P=0.006)。不同性别、年龄及病灶类型对术后发热的发生率无显著影响(P>0.05),且术后发热与吸烟史及基础疾病史无关(P>0.05),但BMI≥24或3 cm ≤病灶直径(d)<6 cm的患者术后更易发热(P<0.05)。 结论超声引导下经皮肺穿刺活检术术后并发症发生率低(约为5.37%),主要为出血及低热,其中术后出血主要与基础疾病史和病灶直径有关,术后发热主要与病灶直径及BMI有关。  相似文献   
4.
5.
Arterial spin labeling (ASL) imaging is a powerful magnetic resonance imaging technique that allows to quantitatively measure blood perfusion non-invasively, which has great potential for assessing tissue viability in various clinical settings. However, the clinical applications of ASL are currently limited by its low signal-to-noise ratio (SNR), limited spatial resolution, and long imaging time. In this work, we propose an unsupervised deep learning-based image denoising and reconstruction framework to improve the SNR and accelerate the imaging speed of high resolution ASL imaging. The unique feature of the proposed framework is that it does not require any prior training pairs but only the subject's own anatomical prior, such as T1-weighted images, as network input. The neural network was trained from scratch in the denoising or reconstruction process, with noisy images or sparely sampled k-space data as training labels. Performance of the proposed method was evaluated using in vivo experiment data obtained from 3 healthy subjects on a 3T MR scanner, using ASL images acquired with 44-min acquisition time as the ground truth. Both qualitative and quantitative analyses demonstrate the superior performance of the proposed txtc framework over the reference methods. In summary, our proposed unsupervised deep learning-based denoising and reconstruction framework can improve the image quality and accelerate the imaging speed of ASL imaging.  相似文献   
6.
综述了脑血管介入术穿刺点压迫方法(包括人工压迫、弹力带加压、压迫器加压、血管闭合装置压迫、止血敷料压迫、气囊加压6种)、止血压力以及压迫时间,提出由于穿刺点和压迫方法的不同,其压迫时间、减压时间和压力大小等需要进一步探讨,为脑血管介入术后患者穿刺点的临床护理提供参考。  相似文献   
7.
The use of radiation for primary liver cancers has historically been limited because of the risk of radiation-induced liver disease. Treatment fields have become more conformal because of several technical advances, and this has allowed for dose escalation. Stereotactic body radiation therapy (SBRT), also known as stereotactic ablative radiotherapy, is now able to safely treat liver tumors to ablative doses while sparing functional liver parenchyma by using highly conformal therapy. Several retrospective and small prospective studies have examined the use of SBRT for liver cancers; however, there is a lack of well-powered randomized studies to definitively guide management in these settings. Recent advances in systemic therapy for primary liver cancers have improved outcomes; however, the optimal selection criteria for SBRT as a local therapy remain unclear among other liver-directed options such as radiofrequency ablation, transarterial chemoembolization, and radioembolization.  相似文献   
8.
Peng  L. Q.  Wu  X. X.  Chen  G.  Cai  H. Z.  Tang  Y. P.  Chen  Q. Y.  Chen  X. Y. 《Bulletin of experimental biology and medicine》2022,173(3):335-340
Bulletin of Experimental Biology and Medicine - This study aimed to explore the effects of Wenyang Zhenshuai granules (WZG) on the morphology of cardiomyocytes, cell viability, and the expression...  相似文献   
9.
目的 观察温阳解郁颗粒(Wenyang Jieyu granule,WYJY)对皮质酮(Corticosterone,CORT)诱导损伤型小鼠海马神经细胞(TH22 cell)的保护作用,基于脑源性神经营养因子(Brain derived neurotrophic factor, BDNF)/酪氨酸激酶B(Tyrosine kinase B, TrkB)/细胞外信号调节蛋白激酶(Extra cellular regulated protein kinases, ERK)信号通路探讨WYJY保护海马神经细胞的作用机制。方法 体外构建小鼠海马神经细胞皮质酮诱导损伤模型,以不同浓度的WYJY和氟西汀(Fluoxetine,FXT)含药血清作用于模型细胞,细胞增殖-毒性检测(Cell Counting Kit-8, CCK-8)法分析细胞活性,倒置显微镜下观察给药前后细胞形态结构的改变,采用蛋白免疫印迹法(Western Blot)、实时荧光定量PCR(Quantitative real-time PCR, qPCR)法检测神经细胞内凋亡因子(BCL2-Associated X, Bax)、抗凋亡因子(B-cell lymphoma-2, Bcl-2)、BDNF、Trkb、ERK以及丝氨酸/苏氨酸激酶(Phospho-p90RSK, RSK)、环磷腺苷效应元件结合蛋白(cAMP-response element binding protein, CREB)蛋白表达水平以及相关基因的表达水平。结果 在浓度为459.5 μmol·L-1的CORT作用24 h后,HT22细胞的活性抑制率达到50%,在此条件作用下细胞形态结构损伤明显,凋亡程度严重,细胞上清中BDNF的含量显著减少(P<0.05),细胞内凋亡相关因子Bax/Bcl-2的比值明显升高(P<0.01),BDNF、Trkb、ERK、RSK、CREB磷酸化蛋白表达水平和mRNA表达水平明显降低(P<0.01);以5%的浓度为2.85 g·kg-1的WYJY和10%的FXT含药血清作用于受损的HT22细胞后,HT22细胞存活率明显提升(P<0.01),细胞结构的损伤明显改善,细胞凋亡程度减轻,细胞外BDNF的含量显著升高(P<0.05),细胞内Bax/Bcl-2比值显著下调(P<0.01),BDNF、Trkb、ERK、RSK、CREB磷酸化蛋白表达水平和mRNA表达水平显著提升(P<0.05,P<0.01)。结论 温阳解郁颗粒可有效保护高浓度CORT造成的小鼠海马神经细胞损伤。调控BDNF/Trkb/ERK通路,放大CREB信号传导,影响Bcl-2、BDNF水平,可能是其保护海马神经元,发挥抗抑郁疗效的重要机制。  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号